Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: A case report and literature review

Amyloid

Volumn 18, Issue 3, 2011, Pages 160-164

  Tsai, Stephanie B ^a   Seldin, David C ^a   Wu, Hao ^a   O'Hara, Carl ^a   Ruberg, Frederick L ^a   Sanchorawala, Vaishali ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

AL amyloidosis; Cardiac amyloidosis; Myocardial infarction; Myocardial ischemia

Indexed keywords

AMYLOID; BISPHOSPHONIC ACID DERIVATIVE; CARMUSTINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GLYCERYL TRINITRATE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON; MELPHALAN; PREDNISONE; THALIDOMIDE; VINCRISTINE;

ADULT; AMYLOIDOSIS; ANGIOCARDIOGRAPHY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; AUTOPSY; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; DRUG MEGADOSE; ECHOCARDIOGRAPHY; HEART AMYLOIDOSIS; HEART INFARCTION; HUMAN; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; STEM CELL MOBILIZATION;

AMYLOID; AMYLOIDOSIS; AUTOPSY; CORONARY VESSELS; ECHOCARDIOGRAPHY; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYOCARDIAL INFARCTION; MYOCARDIUM;

EID: 80052248012     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.571319     Document Type: Article

References (17)

1. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, OHara C, Finn KT, Libbey CA, High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004;140:85-93.
2. Moreau P, Leblond V, Bourquelot P, Facon T, Huynh A, Caillot D, Hermine O, Attal M, Hamidou M, Nedellec G, Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Br J Haematol 1998;101:766-769. (Pubitemid 28308529)
3. Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar S. Transplantation for amyloidosis. Curr Opin Oncol 2007;19:136-141. (Pubitemid 46204353)
4. Goodman HJ, Gillmore JD, Lachmann HJ, Wechalekar AD, Bradwell AR, Hawkins PN. Outcome of autologous stem cell transplantation for AL amyloidosis in the UK. Br J Haematol 2006;134:417-425. (Pubitemid 44079555)
5. Obici L, Perfetti V, Palladini G, Moratti R, Merlini G. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 2005;1753: 11-22. (Pubitemid 41597427)
6. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998;91:141-157. (Pubitemid 28102667)
7. Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med 2000;45:107-137.
8. Mueller PS, Edwards WD, Gertz MA. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med 2000;109:181-188.
9. Neben-Wittich MA, Wittich CM, Mueller PS, Larson DR, Gertz MA, Edwards WD. Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. Am J Med 2005;118:1287.
10. Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Perlini S, Obici L, Ascari E, dEril GM, Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003;107:2440-2445. (Pubitemid 36605226)
11. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, McConnell JP, Litzow MR, Gastineau DA, Tefferi A, Prognostication of survival using cardiac troponins and N-terminal probrain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 2004;104:1881-1887. (Pubitemid 39202301)
12. Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008;51:1022-1030. (Pubitemid 351318125)
13. Kwong RY, Falk RH. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:122-124. (Pubitemid 40139720)
14. Ruberg FL, Appelbaum E, Davidoff R, Ozonoff A, Kissinger KV, Harrigan C, Skinner M, Manning WJ. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 2009;103:544-549.
15. Glaudemans AW, Slart RH, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BP, Dierckx RA. Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging 2009;36:702-714.
16. Ogiwara F, Koyama J, Ikeda S, Kinoshita O, Falk RH. Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis. Am J Cardiol 2005;95:538-540. (Pubitemid 40247560)
17. Pilz G, Klos M, Ali E, Hoefling B, Scheck R, Bernhardt P. Angiographic correlations of patients with small vessel disease diagnosed by adenosine-stress cardiac magnetic resonance imaging. J Cardiovasc Magn Reson 2008;10:8.